Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

(2015) Arndt Weinmann et al.   BMC CANCER

United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board

(2015) Robert G. Gish et al.   CLINICAL TRANSPLANTATION

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States

(2015) Julie K. Heimbach et al.   HEPATOLOGY

Excess mortality on the liver transplant waiting list: Unintended policy consequences and model for End-Stage Liver Disease (MELD) inflation

(2014) Patrick Grant Northup et al.   HEPATOLOGY

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score

(2013) Robert J. Wong et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

(2013) Robert J. Wong et al.   HEPATOLOGY

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list

(2013) Alessandro Vitale et al.   JOURNAL OF HEPATOLOGY

Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010

(2012) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma

(2012) David Goldberg et al.   LIVER TRANSPLANTATION

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants

(2011) Jacqueline G. O'Leary et al.   Clinical Gastroenterology and Hepatology

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

(2011) Michael R. Charlton et al.   GASTROENTEROLOGY

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease

(2011) Srinevas K. Reddy et al.   HEPATOLOGY

Liver Transplantation in the United States, 1999-2008

(2010) P. J. Thuluvath et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System

(2010) K. Washburn et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target

(2009) Kenneth Washburn   Transplantation Reviews

Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival

(2008) George N. Ioannou et al.   GASTROENTEROLOGY

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C

(2008) Satoru Yatsuji et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY